RICHARD HOLLAWELL IN THE MEDIA
Attorney Richard Hollawell has been featured in dozens of major news outlets including The New York Times, The Associated Press, 20/20, and Nightline. He continues to an expert in the field of opioid over-prescription. Learn more about his crusade against the opioid epedemic here.
“Buchalter, along with Patty Nixon, a former employee of Insys, the maker of SUBSYS, and Richard Hollawell, a small town attorney on a crusade against the company, have found a common cause in attempting to hold Insys responsible for what they say is its role in the opioid crisis.”
FEATURED IN NATIONAL NEWS OUTLETS
Richard J. Hollawell has been featured in multiple national news outlets, and his personal injury and opioid over-prescription cases have earned him recognition as an expert in his field. Below are just a few publications featuring our work and dedication to finding justice for victims.
F.D.A. Did Not Intervene to Curb Risky Fentanyl Prescriptions
“A fast-acting class of fentanyl drugs approved only for cancer patients with high opioid tolerance has been prescribed frequently to patients with back pain and migraines…”
Top Executives of Insys, an Opioid Company, Are Found Guilty of Racketeering
“A federal jury on Thursday found the top executives of Insys Therapeutics, a company that sold a fentanyl-based painkiller, guilty of racketeering charges in a rare criminal prosecution that blamed corporate officials for contributing to the nation’s opioid epidemic….”
Families hoping for justice from prescription bribes trial
“Drug company executives weren’t satisfied with sales for their powerful painkiller, so they devised a plan, prosecutors say: Offer cash to doctors in exchange for prescriptions…”
‘Game-changer’ – CEO of fentanyl company found guilty of RICO
“No longer will pharmaceutical companies fear paying only a cost-of-doing business fine for illegally pushing their opioid medications onto an unsuspecting public. Now the executives may face serious prison time after Thursday’s racketeering verdict against John Kapoor, the founder of a company who bribed doctors to amp up their prescribing of a potent fentanyl spray.”
Former CEO said he was made the ‘fall guy’ for opioid maker Insys’
“In the summer of 2015, Michael Babich noticed a marked change in his relationship with John Kapoor, the man who had mentored him and made him CEO of his opioid manufacturing company…”
Billionaire Charged With Bribing Doctors to Prescribe Opioids
“The billionaire owner of Insys Therapeutics was arrested Thursday and charged with leading a nationwide conspiracy to use bribes and fraud to…”
Report: Drug company faked cancer patients to sell
“When Insys Therapeutics got approval to sell an ultra-powerful opioid for cancer patients with acute pain in 2012, it soon discovered a problem: finding enough cancer patients to use the drug…”
Powerful opioid that killed NJ woman likely distributed by Rochester Drug Cooperative
“RDC’s distribution of Subsys was “a link in the criminal, fraudulent scheme that led to the death of Sarah Fuller,” attorneys argue in court papers….”
Cherry Hill mom: Daughter’s opioid death was caused by ‘corporate greed’
“U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc…”
FIRM CASES IN THE NEWS
Our relentless work with victims of opioid over-prescription has been gaining increased importance as the US struggles with the continuing opioid epidemic. Finding justice for victims means digging deeper into the marketing practices of these providers which has led to national attention.
The death of Sarah Fuller of Stratford, NJ due to opioid overdose shed light on some of the shady to downright evil marketing practices of many pharmaceutical companies in the U.S. The opioid epidemic is one of the biggest struggles of our country right now, and we...read more
In a staggering and sickening case against the founder of Insys Therapeutics Inc., the details of the methods used by Insys to boost the sales of their powerful opioid, Subsys, just keep getting more appalling. The company is on trial for racketeering and using their...read more
U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role...read more
Deborah Fuller is clear about what she will tell Sen. Claire McCaskill next week about the pharmaceutical industry’s role in her daughter’s overdose last year: “Basically, you know, they set her up to die.” She will say this in Washington on Tuesday because she has...read more
This week, Sen. Claire McCaskill (D., Mo.) announced a wide-ranging investigation of marketing practices behind the top five prescription painkillers sold in the United States in 2015, including Subsys. Her letter to Insys interim CEO Santosh Vetticadenrequesting a...read more
A federal jury in Philadelphia last week convicted Jeffrey Bado, who formerly practiced in Roxborough and Bryn Mawr, on 308 counts, including 269 of drug distribution and one of drug distribution resulting in death. In October, pill mill kingpin William J. O'Brien III...read more
GET THE HELP YOU DESERVE
$1.65 Million Settlement
A $4,500,000 jury trial verdict (Settled for $1.65 million while
$1.14 Million Settlement
A $1,140,000 total settlement from a doctor who had been overprescribing prescription painkillers and the dispensing pharmacy that led to the patient becoming addicted and subsequently dying from the prescription drugs.
$1.08 Million Settlement
A $1,075,000 settlement for a dram shop case against a bar/restaurant for over-serving a patron who ultimately got behind the wheel of a car intoxicated, seriously injuring our two clients who were passengers in the vehicle when the driver lost control of his car and crashed.
This website is for informational purposes only. Using this site or communicating with Richard J. Hollawell & Associates through this site does not form an attorney/client relationship. This site is legal advertising.